Staphylococcus aureus

Susceptibility
In Vitro Susceptibility of Clinical Staphylococcus aureus Small-Colony Variants to β-Lactam and Non-β-Lactam Antibiotics
Evgeny A. Idelevich, André Kriegeskorte, Nina Schleimer, Georg Peters, Christof von Eiff, Karsten Becker
Open Access

Pharmacology
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells
Frédéric Peyrusson, Paul M. Tulkens, Françoise Van Bambeke
Clinical Therapeutics
Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting
Shaili Adani, Tanaya Bhowmick, Melvin P. Weinstein, Navaneeth Narayanan
Experimental Therapeutics
Prostaglandin E₂ Receptor Antagonist with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus
Mélanie A. C. Ikeh, Paul L. Fidel, Mairi C. Noverr
Experimental Therapeutics
Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice
Roger V. Ortines, Haiyun Liu, Lily I. Cheng, Taylor S. Cohen, Heather Lawlor, Abhishek Gami, Yu Wang, Carly A. Dillen, Nathan K. Archer, Robert J. Miller, Alyssa G. Ashbaugh, Bret L. Pinsker, Mark C. Marchitto, Christine Tkaczyk, C. Kendall Stover, Bret R. Sellman, Lloyd S. Miller
Open Access

Epidemiology and Surveillance
Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus
Glen P. Carter, Mark B. Schultz, Sarah L. Baines, Anders Gonçalves da Silva, Helen Heffernan, Audrey Tiong, Peter H. Pham, Ian R. Monk, Timothy P. Stinear, Benjamin P. Howden, Deborah A. Williamson
Experimental Therapeutics
Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents
S. Hogan, J. P. O'Gara, E. O'Neill
Experimental Therapeutics
Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus
Xuting Zheng, Andrew D. Berti, Sue McCrone, Melanie Roch, Adriana E. Rosato, Warren E. Rose, Baiyi Chen
Mechanisms of Resistance
A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase
Ebaa M. El-Hossary, Konrad U. Förstner, Patrice François, Damien Baud, Karin Streker, Jacques Schrenzel, Knut Ohlsen, Ulrike Holzgrabe
Mechanisms of Resistance
Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility
Stewart G. Gardner, Darrell D. Marshall, Robert S. Daum, Robert Powers, Greg A. Somerville

Main menu

User menu

Search

Staphylococcus aureus

Pages